6 Ways to Evaluate a Stock as a Long-Term Hold

Long-term investing is mostly avoiding mistakes. The companies that compound 15% a year for decades aren't the ones with the highest growth this quarter. They're the ones that combine durable business models, good economics, and rational capital allocation, and that you can buy at a price that makes the math work. Six checks I run before adding a name to a long-term position.

1. Can You Explain the Business in One Sentence

If I can't describe how the company makes money in one sentence to someone who doesn't follow markets, I don't buy it. This isn't a snobbery thing. It's a clarity test. Companies with simple, durable revenue models are easier to think about, easier to monitor, and harder to be surprised by.

“Costco sells groceries and household goods at near-cost margins and makes money on $130 annual memberships.” One sentence. You can hold this company for 20 years without ever needing to update the thesis. Compare to a network-of-networks ad-tech holding company with five business lines and a 30-page deck. The second isn't necessarily worse, but you're going to have to do real work to keep up with it.

2. Does It Have a Real Moat

Moat is the durable advantage that keeps competitors from eroding margins. The five sources I check for:

• Network effects. The product gets more valuable as more people use it. Visa, Meta, Airbnb.
• Switching costs. Customers can't easily leave once they're in. Enterprise SaaS, banking core systems.
• Cost advantages. The company produces at lower cost than anyone else can match. Costco, Walmart, Geico.
• Intangible assets. Brands, patents, regulatory licenses. Coca-Cola, pharma originals, Moody's.
• Efficient scale. The market is only big enough for one or two players. Pipelines, regional airports, rail.

If I can't name which moat the company has and why it's durable, the long-term thesis is shaky. “They have a great product” is not a moat. Any product can be copied. The structural reason the copy fails is the moat.

3. Is the Business Genuinely Profitable

Three numbers I look at:

• Gross margin. Revenue minus cost of goods sold, divided by revenue. Above 40% is healthy. Above 60% is excellent. Below 25% is structurally tough.
• Operating margin. What's left after running the company but before interest and taxes. Persistent operating margins above 15% suggest pricing power.
• Return on invested capital (ROIC). The single most important metric for compounding. ROIC above the company's cost of capital, sustained over years, is what produces long-run shareholder returns.

Companies with high ROIC that can reinvest at the same rate are the ones that compound the hardest. Constellation Software is a textbook case: ROIC north of 25% for two decades, plowed back into more software acquisitions, compounding shareholder capital at 20%+ annualized.

4. Does the Balance Sheet Let It Survive a Bad Year

Long-term winners are the ones that don't go bust during the cyclical downturn that breaks weaker rivals. The checks:

• Net debt to EBITDA below 3x. Some industries can handle more (utilities, REITs). Most can't.
• Interest coverage above 5x. Operating income should comfortably cover interest payments even in a soft year.
• Cash on hand. Companies with meaningful cash reserves can be opportunistic in downturns instead of defensive.

A great company with a leveraged balance sheet is a coin flip. The 2008 crisis took out plenty of well-run businesses that just had too much debt at the wrong moment. Don't assume the next 10 years will be smooth.

5. How Does Management Allocate Capital

Companies generate cash. What they do with it is roughly equal in importance to how much they generate. Five options: reinvest in the business, acquire, pay down debt, buy back stock, pay dividends. Good management chooses among these based on which has the highest expected return per dollar.

Bad management buys back stock at peaks (when shares are expensive) and issues stock at troughs. Bad management makes acquisitions to chase growth that destroys returns. Bad management hoards cash for ego rather than putting it to work or returning it.

Read 10 years of shareholder letters. Look at the buyback history against the stock price over time. Look at the M&A track record (have acquisitions been accretive or written down?). Capital allocation is the part of management quality you can actually measure from outside.

6. Is the Price Sane

A great business at a stupid price is a bad investment. The valuation checks I use:

• P/E ratio compared to its own history and to peers. Not the absolute number, the relative one.
• Free cash flow yield (FCF divided by market cap). Above 5% is reasonable. Above 8% is cheap. Below 3% is expensive.
• EV to EBITDA, especially for companies with debt or cash on the balance sheet, where market cap alone misleads.

For high-growth companies, traditional multiples mislead. The framework I use there is reverse DCF: what growth rate would I need to assume to justify today's price at a 10% discount rate? If the answer is 25%+ for the next decade, the market is already pricing in a perfect outcome. If the answer is 8%, you have margin of safety.

The Take

The list is intentionally low on quantitative tricks and high on judgment. Backtests of pure quantitative strategies look great until they don't. Real long-term winners are the names you'd still be comfortable holding through a 40% drawdown because the underlying business is healthy and the price was reasonable when you bought. The compounding does the work. Your job is to not interrupt it by overpaying or by panicking out of a great business at the wrong moment.